These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32429117)

  • 21. Lovastatin protects against cisplatin-induced hearing loss in mice.
    Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
    Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ototoxicity of 12 mg/kg cisplatin in the Fischer 344/NHsd rat using multiple dosing strategies.
    Harrison RT; Seiler BM; Bielefeld EC
    Anticancer Drugs; 2016 Sep; 27(8):780-6. PubMed ID: 27467178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Remote Ischemic Preconditioning on Systemic Toxicity and Ototoxicity Induced by Cisplatin in Rats: Role of TNF-α and Nitric Oxide.
    Martins MJB; Batista AMA; Brito YNF; Soares PMG; Martins CDS; Ribeiro RA; Brito GAC; de Freitas MR
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(6):336-346. PubMed ID: 29339643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential protein expression profiles in salicylate ototoxicity of the mouse cochlea.
    Jung HH; Kim HJ; Im GJ; Chang J; Choi J; Chae SW
    Hear Res; 2009 Sep; 255(1-2):121-8. PubMed ID: 19540324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
    Bielefeld EC
    Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoguanidine reduces cisplatin ototoxicity.
    Kelly TC; Whitworth CA; Husain K; Rybak LP
    Hear Res; 2003 Dec; 186(1-2):10-6. PubMed ID: 14644455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
    Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
    J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulatory effect of zingerone against cisplatin or γ-irradiation induced hepatotoxicity by molecular targeting regulation.
    Mohamed HE; Badawy MMM
    Appl Radiat Isot; 2019 Dec; 154():108891. PubMed ID: 31536909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protective role of tetramethylpyrazine against cisplatin-induced ototoxicity.
    Bayram A; Kaya A; Akay E; Hıra İ; Özcan İ
    Int J Pediatr Otorhinolaryngol; 2017 Mar; 94():1-7. PubMed ID: 28166996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
    Cheong KO; Shin DS; Bak J; Lee C; Kim KW; Je NK; Chung HY; Yoon S; Moon JO
    Arch Pharm Res; 2016 Feb; 39(2):279-291. PubMed ID: 26667466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial protection by lipoic acid against carboplantin-induced ototoxicity in rats.
    Husain K; Whitworth C; Somani SM; Rybak LP
    Biomed Environ Sci; 2005 Jun; 18(3):198-206. PubMed ID: 16131024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zingerone attenuates vancomycin-induced hepatotoxicity in rats through regulation of oxidative stress, inflammation and apoptosis.
    Kucukler S; Darendelioğlu E; Caglayan C; Ayna A; Yıldırım S; Kandemir FM
    Life Sci; 2020 Oct; 259():118382. PubMed ID: 32898532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pravastatin Administration Alleviates Kanamycin-Induced Cochlear Injury and Hearing Loss.
    Lee CH; Jeon J; Lee SM; Kim SY
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
    Fang B; Xiao H
    Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.